<?xml version="1.0" encoding="UTF-8"?>
<xml>
 <records>
  <record>
   <ref-type name="Journal Article">17</ref-type>
   <contributors>
    <authors>
     <author>Zelinska, N.</author>
     <author>Skorodok, J.</author>
     <author>Skorodok, J.</author>
     <author>Malievsky, O.</author>
     <author>Rosenfeld, R.G.</author>
     <author>Zadik, Z.</author>
     <author>Koren, R.</author>
     <author>Vander, S.</author>
     <author>Hart, G.</author>
     <author>Raduk, D.</author>
    </authors>
   </contributors>
   <titles>
    <title></title>
   </titles>
   <dates>
    <year>2016</year>
    <pub-dates>
     <date>2018-03-06</date>
    </pub-dates>
   </dates>
   <abstract>OPKO Biologics is developing bio-better long-acting&#13;
versions of existing therapeutic proteins utilizing a&#13;
technology called CTP.</abstract>
   <urls>
    <web-urls>
     <url>https://repo.bashgmu.ru/publication/704</url>
    </web-urls>
    <pdf-urls>
     <url>https://repo.bashgmu.ru/files/810</url>
    </pdf-urls>
   </urls>
  </record>
 </records>
</xml>
